Literature DB >> 12213396

Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine.

Thavachai Kamoltham1, Pakamatz Khawplod, Henry Wilde.   

Abstract

Thailand's northern Petchabun province is endemic for canine rabies. There were 27 reported human rabies deaths between 1989 and 1998. A rabies control plan was formulated in 1997 between medical and veterinary public health officials. It started an intense education program and an ongoing dog vaccination campaign. Economic constraints and the high cost of biological were the main reasons for inadequate human post-exposure management (PET). It was therefore decided to use the economical Thai Red Cross Intradermal Vaccine Regimen (TRC-ID) throughout the province. The original TRC-ID method is only suitable for clinics that see more than one PET patient daily. TRC-ID was therefore modified by storing the reconstituted vaccine in a refrigerator for the same patient's next two visits. Data on a total of 8157 PET patients were collected. An additional modification of TRC-ID also eliminated the 90 day booster. There were no treatment failures and no human rabies deaths in 1999, 2000 and 2001. The modified TRC-ID method induces adequate levels of neutralizing antibodies, protects humans bitten by rabid dogs and results in significant savings in vaccine and travel costs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213396     DOI: 10.1016/s0264-410x(02)00299-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.

Authors:  Jung-Eun Park; Hyun-Jin Shin
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

2.  Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.

Authors:  Katie Hampson; Sarah Cleaveland; Deborah Briggs
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

3.  Modelling to inform prophylaxis regimens to prevent human rabies.

Authors:  Katie Hampson; Bernadette Abela-Ridder; Omesh Bharti; Lea Knopf; Monique Léchenne; Rolande Mindekem; Arnaud Tarantola; Jakob Zinsstag; Caroline Trotter
Journal:  Vaccine       Date:  2018-12-07       Impact factor: 4.169

4.  Development in Immunoprophylaxis against Rabies for Animals and Humans.

Authors:  Sukdeb Nandi; Manoj Kumar
Journal:  Avicenna J Med Biotechnol       Date:  2010-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.